<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The investigations were carried out in 30 control cases, in 20 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> transient <z:e sem="disease" ids="C0854112" disease_type="Disease or Syndrome" abbrv="">cerebral circulatory failure</z:e>, 20 patients with intracerebral haemorrhage, and 22 patients with thrombotic <z:e sem="disease" ids="C0014068" disease_type="Disease or Syndrome" abbrv="">encephalomalacia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The determinations of uropepsin activity were done on the 1st, 3rd, 7th and 14th days of the disease </plain></SENT>
<SENT sid="2" pm="."><plain>Uropepsin activity in 24-hour urine was determined by the method of West, Ellis and Scott </plain></SENT>
<SENT sid="3" pm="."><plain>In the group of patients with <z:hpo ids='HP_0011009'>acute</z:hpo> transient <z:e sem="disease" ids="C0854112" disease_type="Disease or Syndrome" abbrv="">cerebral circulatory failure</z:e> abnormalities in urinary uropepsin activity were not significant </plain></SENT>
<SENT sid="4" pm="."><plain>The mean activity of uropepsin in 24-hour urine in patients with intracerebral haemorrhage and <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> on the 1st day of the disease was significantly higher than in controls </plain></SENT>
<SENT sid="5" pm="."><plain>The rise in the activity of this enzyme in patients with <z:e sem="disease" ids="C0014068" disease_type="Disease or Syndrome" abbrv="">encephalomalacia</z:e> was lower in relation to patients with intracerebral haemorrhages </plain></SENT>
<SENT sid="6" pm="."><plain>During improvement of the condition of patients with brain <z:hpo ids='HP_0001297'>stroke</z:hpo> the uropepsin activity in 24-hour urine decreased </plain></SENT>
</text></document>